Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

Symptom Management: Ataxia & Neurological Care

At a Glance

ADCA-DN symptom management cannot stop the underlying genetic progression, but tailored neurologic therapy, fall prevention, swallowing support, cognitive and mood monitoring, and careful neuropathy treatment can improve safety, function, and independence.

Managing the neurological symptoms of Autosomal Dominant Cerebellar Ataxia-Deafness-Narcolepsy Syndrome (ADCA-DN) requires a proactive, multidisciplinary approach. While there is currently no cure to stop the underlying genetic progression, focused care can significantly improve your daily function, safety, and quality of life [1][2].

Because the condition affects several different areas of the nervous system, your care team should ideally include a neurologist, physical and occupational therapists, and specialists in sleep and hearing [1][3].

Strengthening Balance and Mobility

The primary neurological challenge in ADCA-DN is cerebellar ataxia, which affects your coordination and gait. Evidence from similar hereditary ataxias shows that a dedicated, goal-directed exercise program can lead to measurable improvements in balance and independence, though it has not been shown to stop DNMT1-related progression [4][5].

  • Neurologic Physical Therapy: Unlike general physical therapy, neurologic PT focuses specifically on the brain-to-muscle connection. Effective programs often combine balance training, coordination drills (like “finger-to-nose” or “heel-to-shin” exercises), and aerobic activity [5][6]. Note: if you are at risk of falling, coordination drills must be supervised by your therapist.
  • Intensity and Fatigue: It is important to find a balance; while supervised training can be beneficial, many patients with ADCA-DN also struggle with fatigue due to extreme sleepiness. Your neurologic physical therapist must tailor the intensity of your sessions to ensure you don’t become overly exhausted, which can temporarily worsen ataxia symptoms [7][8].
  • Fall Prevention and Aids: As the condition progresses, using mobility aids (like walking sticks or rollators) is a proactive step toward maintaining independence and preventing injuries from falls [4]. An occupational therapist can also perform a “home safety assessment” to identify hazards like loose rugs or poor lighting [9].

Swallowing and Speech Safety

Ataxia can affect the muscles responsible for communication and swallowing, leading to dysarthria (slurred speech).

  • Urgent Red Flags: If you experience coughing or choking with meals, a “wet” sounding voice, unexplained weight loss, or recurrent chest infections, seek prompt medical evaluation.
  • A speech-language pathologist can perform a formal swallow assessment and teach techniques to prevent choking [10].

Monitoring Cognitive and Psychiatric Health

In some individuals with DNMT1-related disorders, the condition can affect “executive function”—the brain’s ability to plan, organize, and multi-task [11].

  • Regular Assessments: It is recommended to establish a “baseline” with a neuropsychological evaluation. This involves a series of tests that measure memory, focus, and problem-solving. Repeating these tests periodically allows your team to catch subtle changes early [12][13].
  • Psychiatric Support: Some patients may experience changes in mood (such as depression or anxiety) or, more rarely, psychosis (hallucinations or delusions) [11][14]. While these can be manifestations of the disease, any new hallucinations, severe mood changes, rapidly worsening confusion, or suicidal thoughts require urgent medical assessment, as they may also reflect medication side effects, sleep deprivation, or delirium [12][15].
  • Engagement: Staying socially active and participating in “cognitively engaging” activities (like hobbies, reading, or puzzles) is encouraged as a way to support brain health [12].

Care for Peripheral Neuropathy

Because ADCA-DN can damage the long nerves that travel to your hands and feet (peripheral neuropathy), you may experience numbness, tingling, or burning pain [16][17].

  • The “Protective” Check: If you lose sensation in your feet, you may not feel a small cut or blister. This can lead to infections if left untreated. It is important to inspect your feet daily for any signs of redness or injury [18].
  • Pain Management: If you experience “neuropathic pain” (burning or electric-shock sensations), there are medications available to help [12]. However, because some of these drugs can cause drowsiness, they must be carefully coordinated with your narcolepsy treatments to avoid excessive daytime sleepiness.
  • Autonomic Awareness: Rarely, neuropathy can affect “automatic” functions like blood pressure or digestion. Let your doctor know if you feel dizzy when standing up or notice significant changes in your bathroom habits [17].

By building a specialized team and focusing on these functional areas, you can take an active role in managing the progression of ADCA-DN and maintaining your day-to-day well-being [1][4].

Common questions in this guide

Can physical therapy help with balance problems from ADCA-DN?
A goal-directed neurologic physical therapy program may improve balance, coordination, mobility, and independence, although it has not been shown to stop DNMT1-related progression. A therapist should supervise challenging exercises and adjust intensity around fatigue and extreme sleepiness.
How can I lower my risk of falls with ADCA-DN?
Walking sticks or rollators can provide support as balance and gait change. An occupational therapist can assess your home and help address hazards such as loose rugs, poor lighting, and other obstacles.
What swallowing changes need prompt medical attention?
Coughing or choking during meals, a wet-sounding voice, unexplained weight loss, or repeated chest infections can signal a swallowing problem and should be assessed promptly. A speech-language pathologist can perform a swallow assessment and teach safer eating and swallowing techniques.
How are cognitive and emotional changes monitored in ADCA-DN?
A baseline neuropsychological evaluation can measure memory, attention, planning, and problem-solving, and repeat testing can reveal subtle changes over time. Depression, anxiety, hallucinations, delusions, severe mood changes, rapidly worsening confusion, or suicidal thoughts should receive prompt or urgent medical assessment.
What should I do about numbness or burning pain in my feet?
Inspect your feet every day for redness, blisters, cuts, or other injuries that reduced sensation could hide. Tell your doctor about burning or electric-shock pain, dizziness when standing, or major bathroom changes so treatment can be considered.
Could neuropathy medicines make ADCA-DN sleepiness worse?
Some medicines used for neuropathic pain can cause drowsiness, which may add to daytime sleepiness from narcolepsy. Your prescribers should coordinate pain and narcolepsy treatments, and you should not change a medicine without medical guidance.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you recommend a physical therapist who specializes in 'neurologic' rehabilitation rather than general orthopedics?
  2. 2.What is my current 'SARA' score, and can we use this to track my balance and coordination over time?
  3. 3.Given the risk of executive dysfunction, how often should I have a formal neuropsychological assessment?
  4. 4.Are there specific medications for neuropathic pain that are less likely to worsen the daytime sleepiness I experience from narcolepsy?
  5. 5.What is the safest way to modify my home to prevent falls as my balance changes (e.g., grab bars, removing rugs)?
  6. 6.If I begin to experience psychiatric symptoms like anxiety or hallucinations, do you work with a neuropsychiatrist who understands neurodegenerative conditions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options.

    Bremova-Ertl T, Hofmann J, Stucki J, et al.

    Cells 2023; (12(18)) doi:10.3390/cells12182314.

    PMID: 37759536
  2. 2

    Evaluation of Cerebellar Ataxic Patients.

    Radmard S, Zesiewicz TA, Kuo SH

    Neurologic clinics 2023; (41(1)):21-44 doi:10.1016/j.ncl.2022.05.002.

    PMID: 36400556
  3. 3

    Epidemiology of Cerebellar Diseases and Therapeutic Approaches.

    Salman MS

    Cerebellum (London, England) 2018; (17(1)):4-11 doi:10.1007/s12311-017-0885-2.

    PMID: 28940047
  4. 4

    Goal-Directed Rehabilitation Versus Standard Care for Individuals with Hereditary Cerebellar Ataxia: A Multicenter, Single-Blind, Randomized Controlled Superiority Trial.

    Milne SC, Roberts M, Williams S, et al.

    Annals of neurology 2025; (97(3)):409-424 doi:10.1002/ana.27130.

    PMID: 39520242
  5. 5

    Effects of physiotherapy on degenerative cerebellar ataxia: a systematic review and meta-analysis.

    Matsugi A, Bando K, Kondo Y, et al.

    Frontiers in neurology 2024; (15()):1491142 doi:10.3389/fneur.2024.1491142.

    PMID: 39866519
  6. 6

    Neurorehabilitation therapy in spinocerebellar ataxia type 2: A 24-week, rater-blinded, randomized, controlled trial.

    Rodríguez-Díaz JC, Velázquez-Pérez L, Rodríguez Labrada R, et al.

    Movement disorders : official journal of the Movement Disorder Society 2018; (33(9)):1481-1487 doi:10.1002/mds.27437.

    PMID: 30132999
  7. 7

    Fatigue Limits Motor and Cognitive Improvements after High-intensity Exercise Prior to Balance Training over Telehealth in People with Spinocerebellar Ataxia.

    Macpherson CE, Awad F, Rana V, et al.

    International journal of telerehabilitation 2025; (17(2)):6713 doi:10.63144/ijt.2025.6713.

    PMID: 41445681
  8. 8

    Extra-Cerebellar Signs and Non-motor Features in Chinese Patients With Spinocerebellar Ataxia Type 3.

    Yuan X, Ou R, Hou Y, et al.

    Frontiers in neurology 2019; (10()):110 doi:10.3389/fneur.2019.00110.

    PMID: 30833927
  9. 9

    Three-Week Video- and Home-Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial.

    Rentz C, Reinhardt A, Jung N, et al.

    Movement disorders clinical practice 2025; (12(12)):2154-2167 doi:10.1002/mdc3.70225.

    PMID: 40654311
  10. 10

    DNMT1-associated sensory neuropathy and cerebellar ataxia: A novel variant and review of genotype-phenotype correlation.

    Menon PJ, Bogdanova-Mihaylova P, McDermott G, et al.

    Journal of the peripheral nervous system : JPNS 2023; (28(3)):508-512 doi:10.1111/jns.12560.

    PMID: 37199681
  11. 11

    Autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN) associated with progressive cognitive and behavioral deterioration.

    Walker LA, Bourque P, Smith AM, Warman Chardon J

    Neuropsychology 2017; (31(3)):292-303 doi:10.1037/neu0000322.

    PMID: 27869457
  12. 12

    Diagnosis and Management of Dementia: Review.

    Arvanitakis Z, Shah RC, Bennett DA

    JAMA 2019; (322(16)):1589-1599 doi:10.1001/jama.2019.4782.

    PMID: 31638686
  13. 13

    Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48).

    Genis D, Ortega-Cubero S, San Nicolás H, et al.

    Neurology 2018; (91(21)):e1988-e1998 doi:10.1212/WNL.0000000000006550.

    PMID: 30381368
  14. 14

    Cerebellar Ataxia-deafness-narcolepsy (ADCA) syndrome. Description of a variable family phenotype.

    Abenza-Abildúa MJ, Palmí-Cortés I, Ojeda-Ruiz de Luna J, et al.

    Acta neurologica Belgica 2025; (125(5)):1395-1399 doi:10.1007/s13760-025-02776-1.

    PMID: 40285998
  15. 15

    Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

    Ismail Z, Creese B, Aarsland D, et al.

    Nature reviews. Neurology 2022; (18(3)):131-144 doi:10.1038/s41582-021-00597-3.

    PMID: 34983978
  16. 16

    Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.

    Baets J, Duan X, Wu Y, et al.

    Brain : a journal of neurology 2015; (138(Pt 4)):845-61 doi:10.1093/brain/awv010.

    PMID: 25678562
  17. 17

    Hummingbird sign in a patient with DNMT1-related disorder.

    Tamura M, Sugiyama A, Hirano S, et al.

    Neurocase 2025; (31(5)):239-244 doi:10.1080/13554794.2025.2560858.

    PMID: 40937613
  18. 18

    The Importance of Offering Exome or Genome Sequencing in Adult Neuromuscular Clinics.

    Dratch L, Bardakjian TM, Johnson K, et al.

    Biology 2024; (13(2)) doi:10.3390/biology13020093.

    PMID: 38392311

This page provides general information about managing ADCA-DN symptoms and does not constitute medical advice. Ask your neurologist and other specialists about a personalized plan, especially for falls, swallowing problems, severe sleepiness, or new psychiatric symptoms.

Get notified when new evidence is published on Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.